![]() |
FAQ | Contact Us | Blog | Partners | News & Events |
Home Page / Contract Research / Lead Discovery / Primary Screening ...
Accelerate drug discovery
Once RapidFire screening methods are developed by the scientists at BIOCIUS, our primary screening service efficiently completes primary screens of test compounds. Compounds may be screened as singletons or in compressed format. RapidFire has been applied to screens of small focused libraries all the way up to large primary compound decks. The quick turn-around-time of RapidFire and user friendly data format enables fast drug identification of hits and lead compounds.
BIOCIUS. Faster Answers.
RapidFire® technology is described in patent numbers 6,932,939, 6,812,030 7,100,460, 7,588,725,